Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Are hematopoietic growth factors useful in the management of drug-induced agranulocytosis?
Autore:
Andres, E; Maloisel, F; Kurtz, JE; Vinzio, S; Sibilia, J; Schlienger, JL; Dufour, P;
Indirizzi:
Hop Hautepierre, Serv Med Interne, F-67098 Strasbourg, France Hop Hautepierre Strasbourg France F-67098 ne, F-67098 Strasbourg, France
Titolo Testata:
REVUE DE MEDECINE INTERNE
fascicolo: 7, volume: 21, anno: 2000,
pagine: 580 - 585
SICI:
0248-8663(200007)21:7<580:AHGFUI>2.0.ZU;2-4
Fonte:
ISI
Lingua:
FRE
Soggetto:
COLONY-STIMULATING FACTOR; SERIES; CSF;
Keywords:
drug-induced agranulocytosis; hematopoietic growth factors;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Andres, E Hop Hautepierre, Serv Med Interne, Ave Moliere, F-67098 Strasbourg, France Hop Hautepierre Ave Moliere Strasbourg France F-67098 g, France
Citazione:
E. Andres et al., "Are hematopoietic growth factors useful in the management of drug-induced agranulocytosis?", REV MED IN, 21(7), 2000, pp. 580-585

Abstract

Purpose. - Our study was aimed at determining the role of hematopoietic growth factor in drug-induced agranulocytosis. Methods. - Fifty-five cases of drug-induced agranulocytosis were reviewed and subdivided retrospectively into a G-CSF group (n = 15) and an untreatedgroup (n = 40). Mortality and hematological recovery (number of days required for neutrophil counts to exceed 1.5 x 10(9)/L) were studied in the two groups. Results. - The mean granulocyte count was 0.09 x 10(9)/L. All patients presented infection. In the G-CSF group, no mortality (0% versus 5%, P = 0.85)and a shorter recovery time (8.1 versus 9.5 days, P = 0.39) were observed. No significant difference between the two groups was observed in either the duration of antibiotic therapy (9.3 days in the G-CSF group versus 10.1 days in the untreated group, P = 0.51) or duration of hospitalization (10 days in the treated group versus 11 days in the G-CSF group, P = 0.46). Conclusion. - Our results as well as a literature review indicate that G-CSF could decrease the time to hematological recovery and perhaps reduce mortality. However, the exact role of hematopoietic growth factors requires further investigations. (C) 2000 Editions scientifiques et medicales ElsevierSAS.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/01/20 alle ore 19:28:01